Belite Bio’s Tinlarebant positive phase III result for Stargardt disease
December 2, 2025

Belite Bio’s Tinlarebant Delivers Positive Phase III Results for Stargardt Disease

A rare win in Stargardt research breathes fire into a field long stuck in slow motion.  In a field where…

Heidelberg_EssilorLuxottica_symposium_thumbnail_(1)
November 14, 2025

SYFOVRE 5-Year GALE Analysis Shows ~1.5-Year Delay in GA Progression in Nonsubfoveal Disease

Five-year data extend structural benefits but highlight ongoing gaps in functional outcomes Long-term data in geographic atrophy (GA) is rare,…

Discover our fascinating content at issuu

explore